7 authorised products containing Sirolimus, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| HYFTOR 2 mg/g Gel EU/1/23/1723/001 |
Sirolimus | Plusultra Pharma GmbH | — |
| Rapamune EU/1/01/171/14 |
Sirolimus | Pfizer Europe MA EEIG | — |
| Rapamune 0.5 mg Coated tablet EU/1/01/171/013-014 |
Sirolimus | Pfizer Europe MA EEIG | — |
| Rapamune 1 mg Coated tablet EU/1/01/171/007 |
Sirolimus | Pfizer Europe MA EEIG | — |
| Rapamune 1 mg Coated tablet EU/1/01/171/008 |
Sirolimus | Pfizer Europe MA EEIG | — |
| Rapamune 1 mg/ml Oral solution EU/1/01/171/001 |
Sirolimus | Pfizer Europe MA EEIG | — |
| Rapamune 2 mg Coated tablet EU/1/01/171/009-010 |
Sirolimus | Pfizer Europe MA EEIG | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.